Transient Co-Expression of Post-Transcriptional Gene Silencing Suppressors for Increased in Planta Expression of a Recombinant Anthrax Receptor Fusion Protein

Potential epidemics of infectious diseases and the constant threat of bioterrorism demand rapid, scalable, and cost-efficient manufacturing of therapeutic proteins. Molecular farming of tobacco plants provides an alternative for the recombinant production of therapeutics. We have developed a transient production platform that uses Agrobacterium infiltration of Nicotiana benthamiana plants to express a novel anthrax receptor decoy protein (immunoadhesin), CMG2-Fc. This chimeric fusion protein, designed to protect against the deadly anthrax toxins, is composed of the von Willebrand factor A (VWA) domain of human capillary morphogenesis 2 (CMG2), an effective anthrax toxin receptor, and the Fc region of human immunoglobulin G (IgG). We evaluated, in N. benthamiana intact plants and detached leaves, the expression of CMG2-Fc under the control of the constitutive CaMV 35S promoter, and the co-expression of CMG2-Fc with nine different viral suppressors of post-transcriptional gene silencing (PTGS): p1, p10, p19, p21, p24, p25, p38, 2b, and HCPro. Overall, transient CMG2-Fc expression was higher on intact plants than detached leaves. Maximum expression was observed with p1 co-expression at 3.5 days post-infiltration (DPI), with a level of 0.56 g CMG2-Fc per kg of leaf fresh weight and 1.5% of the total soluble protein, a ten-fold increase in expression when compared to absence of suppression. Co-expression with the p25 PTGS suppressor also significantly increased the CMG2-Fc expression level after just 3.5 DPI

Polyploidization as a Retraction Force in Plant Genome Evolution: Sequence Rearrangements in Triticale

BACKGROUND: Polyploidization is a major evolutionary process in plants where hybridization and chromosome doubling induce enormous genomic stress and can generate genetic and epigenetic modifications. However, proper evaluation of DNA sequence restructuring events and the precise characterization of sequences involved are still sparse. METHODOLOGY/PRINCIPAL FINDINGS: Inter Retrotransposons Amplified Polymorphism (IRAP), Retrotransposons Microsatellite Amplified Polymorphism (REMAP) and Inter Simple Sequence Repeat (ISSR) largely confirmed the absence of any intraspecific variation in wheat, rye and triticale. The comparative analysis of banding profiles between wheat and rye inbred lines revealed 34% of monomorphic (common to both parental species) bands for the ten different primer combinations used. The analysis of triticale plants uncovered nearly 51% of rearranged bands in the polyploid, being the majority of these modifications, due to the loss of rye bands (83%). Sequence analysis of rye fragments absent in triticale revealed for instance homology with hydroxyproline-rich glycoproteins (HRGP), a protein that belongs to a major family of inducible defence response proteins. Conversely, a wheat-specific band absent in triticale comprises a nested structure of copia-like retrotransposons elements, namely Claudia and Barbara. Sequencing of a polyploid-specific band (absent in both parents) revealed a microsatellite related sequence. Cytological studies using Fluorescent In Situ Hybridization (FISH) with REMAP products revealed a widespread distribution of retrotransposon and/or microsatellite flanking sequences on rye chromosomes, with a preferential accumulation in heterochromatic sub-telomeric domains. CONCLUSIONS/SIGNIFICANCE: Here, we used PCR-based molecular marker techniques involving retrotransposons and microsatellites to uncover polyploidization induced genetic restructuring in triticale. Sequence analysis of rearranged genomic fragments either from rye or wheat origin showed these to be retrotransposon-related as well as coding sequences. Further FISH analysis revealed possible chromosome hotspots for sequence rearrangements. The role of chromatin condensation on the origin of genomic rearrangements mediated by polyploidization in triticale is also discussed

Combinatorial Analysis of Secretory Immunoglobulin A (sIgA) Expression in Plants

Delivery of secretory immunoglobulin A (sIgA) to mucosal surfaces as a passive immunotherapy agent is a promising strategy to prevent infectious diseases. Recombinant sIgA production in plants requires the co-expression of four transcriptional units encoding the light chain (LC), heavy chain (HC), joining chain (JC) and secretory component (SC). As a way to optimize sIgA production in plants, we tested the combinatorial expression of 16 versions of a human sIgA against the VP8* rotavirus antigen in Nicotiana benthamiana, using the recently developed GoldenBraid multigene assembly system. Each sIgA version was obtained by combining one of the two types of HC (alpha 1 and alpha 2) with one of the two LC types (k and lambda) and linking or not a KDEL peptide to the HC and/or SC. From the analysis of the anti-VP8* activity, it was concluded that those sIgA versions carrying HC alpha 1 and LC lambda provided the highest yields. Moreover, ER retention significantly increased antibody production, particularly when the KDEL signal was linked to the SC. Maximum expression levels of 32.5 mu g IgA/g fresh weight (FW) were obtained in the best performing combination, with an estimated 33% of it in the form of a secretory complex.This work has been funded by Grant BIO2010-15384 from Plan Nacional I + D of the Spanish Ministry of Science. Juarez P. is a recipient of a FPU fellowship, and Sarrion-Perdigones A. and Huet-Trujillo E. are recipients of a FPI fellowship. We want to thank Monedero for kindly providing scFv and VP8* clones.Juárez Ortega, P.; Huet Trujillo, E.; Sarrion-Perdigones, A.; Falconi, E.; Granell Richart, A.; Orzáez Calatayud, DV. (2013). Combinatorial Analysis of Secretory Immunoglobulin A (sIgA) Expression in Plants. International Journal of Molecular Sciences. 14(3):6205-6222. https://doi.org/10.3390/ijms14036205S62056222143Reichert, J. M., & Valge-Archer, V. E. (2007). Development trends for monoclonal antibody cancer therapeutics. Nature Reviews Drug Discovery, 6(5), 349-356. doi:10.1038/nrd2241Corthésy, B. (2010). Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces. Future Microbiology, 5(5), 817-829. doi:10.2217/fmb.10.39Corthésy, B. (2003). Recombinant Secretory Immunoglobulin A in Passive Immunotherapy: Linking Immunology and Biotechnology. Current Pharmaceutical Biotechnology, 4(1), 51-67. doi:10.2174/1389201033378020Corthësy, B. (2008). Secretory immunoglobulin A: well beyond immune exclusion at mucosal surfaces. Immunopharmacology and Immunotoxicology, 31(2), 174-179. doi:10.1080/08923970802438441Sarrion-Perdigones, A., Juarez, P., Granell, A., & Orzaez, D. (2011). Production of Antibodies in Plants. Cell Engineering, 143-164. doi:10.1007/978-94-007-1257-7_7Paul, M., Dolleweerd, C. van, Drake, P. M. W., Reljic, R., Thangaraj, H., Barbi, T., … Ma, J. K.-C. (2011). Molecular pharming. Human Vaccines, 7(3), 375-382. doi:10.4161/hv.7.3.14456Fischer, R., Stoger, E., Schillberg, S., Christou, P., & Twyman, R. M. (2004). Plant-based production of biopharmaceuticals. Current Opinion in Plant Biology, 7(2), 152-158. doi:10.1016/j.pbi.2004.01.007Twyman, R. M., Stoger, E., Schillberg, S., Christou, P., & Fischer, R. (2003). Molecular farming in plants: host systems and expression technology. Trends in Biotechnology, 21(12), 570-578. doi:10.1016/j.tibtech.2003.10.002Saint-Jore-Dupas, C., Faye, L., & Gomord, V. (2007). From planta to pharma with glycosylation in the toolbox. Trends in Biotechnology, 25(7), 317-323. doi:10.1016/j.tibtech.2007.04.008Ma, J., Hiatt, A., Hein, M., Vine, N., Wang, F., Stabila, P., … Lehner, T. (1995). Generation and assembly of secretory antibodies in plants. Science, 268(5211), 716-719. doi:10.1126/science.7732380Ma, J. K.-C., Hikmat, B. Y., Wycoff, K., Vine, N. D., Chargelegue, D., Yu, L., … Lehner, T. (1998). Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nature Medicine, 4(5), 601-606. doi:10.1038/nm0598-601Weintraub, J. A., Hilton, J. F., White, J. M., Hoover, C. I., Wycoff, K. L., Yu, L., … Featherstone, J. D. B. (2005). Clinical Trial of a Plant-Derived Antibody on Recolonization of Mutans Streptococci. Caries Research, 39(3), 241-250. doi:10.1159/000084805Wycoff, K. (2005). Secretory IgA Antibodies from Plants. Current Pharmaceutical Design, 11(19), 2429-2437. doi:10.2174/1381612054367508Nicholson, L., Gonzalez-Melendi, P., Van Dolleweerd, C., Tuck, H., Perrin, Y., Ma, J. K.-C., … Stoger, E. (2004). A recombinant multimeric immunoglobulin expressed in rice shows assembly-dependent subcellular localization in endosperm cells. Plant Biotechnology Journal, 3(1), 115-127. doi:10.1111/j.1467-7652.2004.00106.xWieland, W. H., Lammers, A., Schots, A., & Orzáez, D. V. (2006). Plant expression of chicken secretory antibodies derived from combinatorial libraries. Journal of Biotechnology, 122(3), 382-391. doi:10.1016/j.jbiotec.2005.12.020Larrick, J. W., Yu, L., Naftzger, C., Jaiswal, S., & Wycoff, K. (2001). Production of secretory IgA antibodies in plants. Biomolecular Engineering, 18(3), 87-94. doi:10.1016/s1389-0344(01)00102-2FOLEY, R. C., RAISONS, R. L., & BEH, K. J. (1991). Monoclonal Antibody Against Sheep Kappa Light Chain. Hybridoma, 10(4), 507-515. doi:10.1089/hyb.1991.10.507Furtado, P. B., Whitty, P. W., Robertson, A., Eaton, J. T., Almogren, A., Kerr, M. A., … Perkins, S. J. (2004). Solution Structure Determination of Monomeric Human IgA2 by X-ray and Neutron Scattering, Analytical Ultracentrifugation and Constrained Modelling: A Comparison with Monomeric Human IgA1. Journal of Molecular Biology, 338(5), 921-941. doi:10.1016/j.jmb.2004.03.007De Muynck, B., Navarre, C., & Boutry, M. (2010). Production of antibodies in plants: status after twenty years. Plant Biotechnology Journal, 8(5), 529-563. doi:10.1111/j.1467-7652.2009.00494.xMa, J. K.-C., Drake, P. M. W., & Christou, P. (2003). The production of recombinant pharmaceutical proteins in plants. Nature Reviews Genetics, 4(10), 794-805. doi:10.1038/nrg1177De Muynck, B., Navarre, C., Nizet, Y., Stadlmann, J., & Boutry, M. (2009). Different subcellular localization and glycosylation for a functional antibody expressed in Nicotiana tabacum plants and suspension cells. Transgenic Research, 18(3), 467-482. doi:10.1007/s11248-008-9240-1D�ring, K., Hippe, S., Kreuzaler, F., & Schell, J. (1990). Synthesis and self-assembly of a functional monoclonal antibody in transgenic Nicotiana tabacum. Plant Molecular Biology, 15(2), 281-293. doi:10.1007/bf00036914Wilde, C. D., Rycke, R. D., Beeckman, T., Neve, M. D., Montagu, M. V., Engler, G., & Depicker, A. (1998). Accumulation Pattern of IgG Antibodies and Fab Fragments in Transgenic Arabidopsis thaliana Plants. Plant and Cell Physiology, 39(6), 639-646. doi:10.1093/oxfordjournals.pcp.a029416Schouten, A., Roosien, J., van Engelen, F. A., (Ineke) de Jong, G. A. M., (Tanja) Borst-Vrenssen, A. W. M., Zilverentant, J. F., … Bakker, J. (1996). The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco. Plant Molecular Biology, 30(4), 781-793. doi:10.1007/bf00019011Bencurova, M. (2004). Specificity of IgG and IgE antibodies against plant and insect glycoprotein glycans determined with artificial glycoforms of human transferrin. Glycobiology, 14(5), 457-466. doi:10.1093/glycob/cwh058Gomord, V., Fitchette, A.-C., Menu-Bouaouiche, L., Saint-Jore-Dupas, C., Plasson, C., Michaud, D., & Faye, L. (2010). Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnology Journal, 8(5), 564-587. doi:10.1111/j.1467-7652.2009.00497.xSarrion-Perdigones, A., Falconi, E. E., Zandalinas, S. I., Juárez, P., Fernández-del-Carmen, A., Granell, A., & Orzaez, D. (2011). GoldenBraid: An Iterative Cloning System for Standardized Assembly of Reusable Genetic Modules. PLoS ONE, 6(7), e21622. doi:10.1371/journal.pone.0021622Weber, E., Engler, C., Gruetzner, R., Werner, S., & Marillonnet, S. (2011). A Modular Cloning System for Standardized Assembly of Multigene Constructs. PLoS ONE, 6(2), e16765. doi:10.1371/journal.pone.0016765Monedero, V., Rodriguez-Diaz, J., Viana, R., Buesa, J., & Perez-Martinez, G. (2004). Selection of Single-Chain Antibodies against the VP8* Subunit of Rotavirus VP4 Outer Capsid Protein and Their Expression in Lactobacillus casei. Applied and Environmental Microbiology, 70(11), 6936-6939. doi:10.1128/aem.70.11.6936-6939.2004Juárez, P., Presa, S., Espí, J., Pineda, B., Antón, M. T., Moreno, V., … Orzaez, D. (2011). Neutralizing antibodies against rotavirus produced in transgenically labelled purple tomatoes. Plant Biotechnology Journal, 10(3), 341-352. doi:10.1111/j.1467-7652.2011.00666.xLangley, R., Wines, B., Willoughby, N., Basu, I., Proft, T., & Fraser, J. D. (2005). The Staphylococcal Superantigen-Like Protein 7 Binds IgA and Complement C5 and Inhibits IgA-FcαRI Binding and Serum Killing of Bacteria. The Journal of Immunology, 174(5), 2926-2933. doi:10.4049/jimmunol.174.5.2926Sack, M., Paetz, A., Kunert, R., Bomble, M., Hesse, F., Stiegler, G., … Rademacher, T. (2007). Functional analysis of the broadly neutralizing human anti-HIV-1 antibody 2F5 produced in transgenic BY-2 suspension cultures. The FASEB Journal, 21(8), 1655-1664. doi:10.1096/fj.06-5863comRamessar, K., Rademacher, T., Sack, M., Stadlmann, J., Platis, D., Stiegler, G., … Christou, P. (2008). Cost-effective production of a vaginal protein microbicide to prevent HIV transmission. Proceedings of the National Academy of Sciences, 105(10), 3727-3732. doi:10.1073/pnas.0708841104Brandtzaeg, P., & Prydz, H. (1984). Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins. Nature, 311(5981), 71-73. doi:10.1038/311071a0Johansen, Braathen, & Brandtzaeg. (2000). Role of J Chain in Secretory Immunoglobulin Formation. Scandinavian Journal of Immunology, 52(3), 240-248. doi:10.1046/j.1365-3083.2000.00790.xBraathen, R., Hohman, V. S., Brandtzaeg, P., & Johansen, F.-E. (2007). Secretory Antibody Formation: Conserved Binding Interactions between J Chain and Polymeric Ig Receptor from Humans and Amphibians. The Journal of Immunology, 178(3), 1589-1597. doi:10.4049/jimmunol.178.3.1589Murthy, A. K., Chaganty, B. K. R., Troutman, T., Guentzel, M. N., Yu, J.-J., Ali, S. K., … Arulanandam, B. P. (2011). Mannose-Containing Oligosaccharides of Non-Specific Human Secretory Immunoglobulin A Mediate Inhibition of Vibrio cholerae Biofilm Formation. PLoS ONE, 6(2), e16847. doi:10.1371/journal.pone.0016847Mathias, A., & Corthésy, B. (2011). N-Glycans on secretory component. Gut Microbes, 2(5), 287-293. doi:10.4161/gmic.2.5.18269Hu, L., Crawford, S. E., Czako, R., Cortes-Penfield, N. W., Smith, D. F., Le Pendu, J., … Prasad, B. V. V. (2012). Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature, 485(7397), 256-259. doi:10.1038/nature10996Yu, X., Dang, V. T., Fleming, F. E., von Itzstein, M., Coulson, B. S., & Blanchard, H. (2012). Structural Basis of Rotavirus Strain Preference toward N-Acetyl- or N-Glycolylneuraminic Acid-Containing Receptors. Journal of Virology, 86(24), 13456-13466. doi:10.1128/jvi.06975-11Haselhorst, T., Fleming, F. E., Dyason, J. C., Hartnell, R. D., Yu, X., Holloway, G., … von Itzstein, M. (2008). Sialic acid dependence in rotavirus host cell invasion. Nature Chemical Biology, 5(2), 91-93. doi:10.1038/nchembio.134Bonner, A., Almogren, A., Furtado, P. B., Kerr, M. A., & Perkins, S. J. (2008). The Nonplanar Secretory IgA2 and Near Planar Secretory IgA1 Solution Structures Rationalize Their Different Mucosal Immune Responses. Journal of Biological Chemistry, 284(8), 5077-5087. doi:10.1074/jbc.m807529200Yoo, E. M., & Morrison, S. L. (2005). IgA: An immune glycoprotein. Clinical Immunology, 116(1), 3-10. doi:10.1016/j.clim.2005.03.010Karnoup, A. S., Turkelson, V., & Anderson, W. H. K. (2005). O-Linked glycosylation in maize-expressed human IgA1. Glycobiology, 15(10), 965-981. doi:10.1093/glycob/cwi077Ramsland, P. A., Willoughby, N., Trist, H. M., Farrugia, W., Hogarth, P. M., Fraser, J. D., & Wines, B. D. (2007). Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1. Proceedings of the National Academy of Sciences, 104(38), 15051-15056. doi:10.1073/pnas.0706028104Almogren, A., Senior, B. W., & Kerr, M. A. (2007). A comparison of the binding of secretory component to immunoglobulin A (IgA) in human colostral S-IgA1 and S-IgA2. Immunology, 120(2), 273-280. doi:10.1111/j.1365-2567.2006.02498.xOrzaez, D., Mirabel, S., Wieland, W. H., & Granell, A. (2006). Agroinjection of Tomato Fruits. A Tool for Rapid Functional Analysis of Transgenes Directly in Fruit. Plant Physiology, 140(1), 3-11. doi:10.1104/pp.105.06822

Biomanufacturing of protective antibodies and other therapeutics in edible plant tissues for oral applications

[EN] Although plant expression systems used for production of therapeutic proteins have the advantage of being scalable at a low price, the downstream processing necessary to obtain pure therapeutic molecules is as expensive as for the traditional Chinese hamster ovary (CHO) platforms. However, when edible plant tissues (EPTs) are used, there is no need for exhaustive purification, because they can be delivered orally as partially purified formulations that are safe for consumption. This economic benefit is especially interesting when high doses of recombinant proteins are required throughout the treatment/prophylaxis period, as is the case for antibodies used for oral passive immunization (OPI). The secretory IgA (SIgA) antibodies, which are highly abundant in the digestive tract and mucosal secretions, and thus the first choice for OPI, have only been successfully produced in plant expression systems. Here, we cover most of the up-todate examples of EPT-produced pharmaceuticals, including two examples of SIgA aimed at oral delivery. We describe the benefits and drawbacks of delivering partially purified formulations and discuss a number of practical considerations and criteria to take into account when using plant expression systems, such as subcellular targeting, protein degradation, glycosylation patterns and downstream strategies, all crucial for improved yield, high quality and low cost of the final product.The authors would like to thank Annick Bleys for assistance with the manuscript preparation. P.J. would like to express gratitude towards the Spanish Ministry of Economy and Competiveness for her FPU fellowship and towards the International Society for Plant Molecular Farming for their generous bursaries for attending the PBVAB 2015. This work was supported by grants from Research Foundation Flanders (FWO project G0C9714N), from the European Commission (H2020-MSCA-IF-2014 Proposal 658701-ImmunoFarm) and from the Spanish Ministry of Economy and Competiveness (Plan Nacional I+D Grant BIO2013-42193R).Juarez, P.; Virdi, V.; Depicker, A.; Orzáez Calatayud, DV. (2016). Biomanufacturing of protective antibodies and other therapeutics in edible plant tissues for oral applications. Plant Biotechnology Journal. 14(9):1791-1799. https://doi.org/10.1111/pbi.12541S1791179914

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead